Expression of 11β-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor in primary lung carcinomas

Anticancer Research

Volumn 20, Issue 1 A, 2000, Pages 323-328

  Suzuki, Satoshi ^a   Suzuki, Takashi ^b   Tsubochi, Hiroyoshi ^b   Koike, Kaoru ^c   Tateno, Hiroo ^c   Krozowski, Zygmunt S ^d   Sasano, Hironobu ^b  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Miyagi Cancer Center   (Japan)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

11 hydroxysteroid dehydrogenase type 2; Differentiation; Immunohistochemistry; Mineralocorticoid receptor; Primary lung carcinomas

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; MINERALOCORTICOID RECEPTOR; REAGENT;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; CANCER GRADING; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; FEMALE; HUMANS; HYDROXYSTEROID DEHYDROGENASES; ISOENZYMES; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RECEPTORS, MINERALOCORTICOID;

EID: 0034068495     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Funder JW, Pearce PT, Smith R, Smith AI: Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242: 583-585, 1988.
2. Edwards CR, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, DeKloet ER, Monder C: Localization of 11β-hydroxysteroid dehydrogenase: tissue specific protector of the mineralocorticoid receptor. Lancet 2: 986-989, 1988.
3. Albiston, AL, Obeyesekere VR, Smith RE, Krozowski ZS: Cloning and tissue specific distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 105: R11-R17, 1994.
4. Shimojo M, Ricketts ML, Petrelli MD, Jonson SD, Bradwell AR, Hewison H, Howie AJ, Stewart PM: Immunolocalization of 11β-hydroxysteroid dehydrogenase type 2 in human mineralocorticoid target tissue: evidence for nuclear localization. Endocrinol 138: 1305-1311, 1997.
5. Hirasawa G, Sasano H, Takahashi K, Fukushima K, Suzuki T, Hiwatashi N, Toyama T, Krozowski ZS, Nagura H: Colocalization of 11β-hydroxysteroid dehydrogenase type II and mineralocorticoid receptor in human epithelia. J Clin Endocrinol Metab 82: 3859-3863, 1997.
6. Welsh MJ: Electrolyte transport by airway epithelia. Physiol Rev 67: 1143-1184, 1987.
7. Matthay MA, Folkesson HG, Verkman AS: Salt and water transport across alveolar and distal airway epithelia in the adult lung. Am J Physiol 270: L487-L503, 1993.
8. Matalon S, Benos DJ, Jackson RM: Biophysical and molecular properties of amiloride-inhibitable Na+ channels in alveolar epithelial cells. Am J Physiol 271: L1-L22, 1996.
9. Hooper SB, Harding R: Fetal lung liquid: a major determinant of the growth and functional development of the fetal lung. Clin Exp Pharmacol Physiol 22: 235-247, 1995.
10. Widdicombe J: Relationship among the composition of mucus, epithelial lining liquid and adhesion of microorganisms. Am J Respir Crit Care Med 151: 2088-2093, 1995.
11. Suzuki T, Sasano H, Suzuki S, Hirasawa G, Takeyama J, Muramatsu Y, Date F, Nagura H, Krozowski ZS: 11β-hydroxysteroid dehydrogenase type 2 in human lung: possible regulator of mineralocorticoid action. J Clic Endocrinol Metab 83: 4022-4025, 1998.
12. Krozowski ZS, Maguire JA, Stein-Oakley AN, Dowling J, Smith RE, Andrews RK: Immunohistochemical localization of the 11β-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J Clin Endocrin Metab 80: 2203-2209, 1995.
13. Krozowski ZS, Rundle SE, Wallace C, Castell MJ, Shen JH, Dowing J, Funder JW, Smith AI: Immunolocalization of renal mineralocorticoid receptors with an antiserum against a peptide deduced from the complementary deoxynucleic acid sequence. Endocrinology 125: 192-198, 1989.
14. Sasano H, Fukushima K, Sasaki I, Matsuno S, Nagura H, Krozowski ZS: Immunolocalization of mineralocorticoid receptor in human kidney, pancreas, salivary, mammary and sweat glands: a light and electron microscopic immunohistological study. J Endocrinol 132: 305-310, 1992.
15. Blobel GA, Moll R, Franke WW, Vogt-Moykopf I: Cytokeratins in normal lung and lung carcinomas. 1. Adenocarcinomas, squamous cell carcinomas and cultured cell lines. Virchows Archiv 45: 407-429, 1984.
16. Kawai T, Hiroi S, Hanai N, Shitara K. KM195 as an immunohistochemical marker of adenocarcinoma of the lung. Lung Cancer 15: 41-50, 1996.
17. Singh G, Katyal SL, Torikata C: Carcinoma of type II pneumocytes: immunodiagnosis of a subtype of bronchiolo-alveolar carcinomas. Am J Pathol 102: 195-208, 1981.
18. Dempo K, Satoh M, Tsuji S, Mori M, Kuroki Y, Akino T: Immunohistochemical studies on the expression of pulmonary surfactant apoproteins in human lung carcinomas using monoclonal antibodies. Path Res Pract 182: 669-675, 1987.
19. Mizutani Y, Nakajima T, Morinaga S, Gotoh M, Shimosato Y, Akino T, Suzuki A: Immunohistochemical localization of pulmonary surfactant apoproteins in various lung tumors. Cancer 61: 532-537, 1988.
20. Wohlford-Lenane CL, Snyder JM: Localization of surfactant-associated proteins SP-A and SP-B mRNA in rabbit fetal lung tissue by in situ hybridization. Am J Respir Cell Mol Biol 7: 335-343, 1992.
21. Sasano H, Frost AR, Saitoh R, Matsunaga G, Nagura H, Krozowski ZS, Siverberg SG: Localization of mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase type II in human breast and its disorders. Anticancer Research 17: 2001-2008, 1997.
22. Takahashi K, Sasano H, Fukushima K, Hirasawa G, Miura H, Sasaki I, Krozowski ZS, Nagura H: 11β-hydroxysteroid dehydrogenase type 11 in human colon: a new marker of fetal development and differentiation in neoplasms. Anticancer Research 18: 3381-3388, 1999
23. Smith RE, Salamonsen LA, Komesaroff PA, Li KX, Myles KM, Lawrence M, Krozowski ZS: 11β-hydroxysteroid dehydrogenase type II in the human endometrium: localization and activity during the menstrual cycle. J Clin Endocrin Metab 82: 7252-7257, 1947.
24. Naray-Fejes-Toth A, Fejes-Toth G: Extranuclear localization of endogenous 11β-hydroxysteroid dehydrogenase-2 in aldosterone target cells. Endocrinology 139: 2955-2954, 1998.
25. Mason RJ, Williams MC, Widdicombe JH, Sanders MJ, Misfeldt DS, Berry LC: Transepithelial transport by pulmonary alveolar type II cells in primary culture. Proc Natl Acad Sci USA 79: 6033-6037, 1982.
26. O'Brodovich H, Rafii B, Post M: Bioelectric properties of fetal alveolar epithelial monolayers. Am J Physiol 258: L201-L206, 1990.
27. Walker BR, Campbell JC, Williams BC, Edwards CR: Tissue-specific distribution of the NAD+-dependent isoform of 11β-hydroxysteroid dehydrogenase. Endocrinology 131: 970-972, 1992.
28. Zhou MY, Gomez-Sanches EP, Cox DL, Cosby D, Gomez-Sanches CE: Cloning, expression, and tissue distribution of the rat nicotinamide adenine dinucleotide-dependent 11β-hydroxysteroid dehydrogenase. Endocrinology 136: 3729-3734, 1995.
29. Krozowski ZS, Funder JW: Mineralocorticoid receptors in the rat lung. Endocrinology 109: 1811-1813, 1981.
30. Suzuki S, Tsubochi H, Noda M, Sugita M, Kubo H, Ono S, Suzuki T, Fujimura S: Increase in the amiloride-sensitive alveolar fluid absorption in rats treated with low-sodium diet. Am J Respir Crit Care Med 159: A290, 1999.